Wolfgang Eisterer

2.7k total citations
95 papers, 1.7k citations indexed

About

Wolfgang Eisterer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Wolfgang Eisterer has authored 95 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 36 papers in Pulmonary and Respiratory Medicine and 24 papers in Surgery. Recurrent topics in Wolfgang Eisterer's work include Colorectal Cancer Treatments and Studies (26 papers), Gastric Cancer Management and Outcomes (21 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Wolfgang Eisterer is often cited by papers focused on Colorectal Cancer Treatments and Studies (26 papers), Gastric Cancer Management and Outcomes (21 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Wolfgang Eisterer collaborates with scholars based in Austria, Germany and Switzerland. Wolfgang Eisterer's co-authors include J. Thaler, Reinhard Stauder, Ursula Günthert, Connie J. Eaves, Josef Thaler, Wolfgang Hilbe, Hanno Glimm, Tessa L. Holyoake, Oliver Bechter and Xiaoyan Jiang and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Investigation.

In The Last Decade

Wolfgang Eisterer

92 papers receiving 1.7k citations

Peers

Countries citing papers authored by Wolfgang Eisterer

Since Specialization

Citations

This map shows the geographic impact of Wolfgang Eisterer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Eisterer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Eisterer more than expected).

Fields of papers citing papers by Wolfgang Eisterer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Eisterer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Eisterer. The network helps show where Wolfgang Eisterer may publish in the future.

Co-authorship network of co-authors of Wolfgang Eisterer

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Eisterer. A scholar is included among the top collaborators of Wolfgang Eisterer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Eisterer. Wolfgang Eisterer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 Trial 2024 ·Cancers ·(unknown), Jonas Santol, Birgit Gruenberger, A. Lenauer, Friedrich Laengle, Josef Thaler, (unknown), Wolfgang Eisterer, Angela Djanani, Judith Stift, Thomas Gruenberger	1
2	German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer 2023 ·Gastric Cancer ·Florian Lordick, Salah‐Eddin Al‐Batran, Dirk Arnold, Markus Borner, Christiane J. Bruns, Wolfgang Eisterer, (unknown), Ines Gockel, Dieter Köberle, Sylvie Lorenzen, Markus Möhler, Ron Pritzkuleit, M. Stahl, Peter Thuss‐Patience, Ewald Wöll, Thomas Zander, Georg Maschmeyer	3
3	Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus on Systemic Therapy – An Update 2023 ·Anticancer Research ·Ewald Wöll, Arno Amann, Wolfgang Eisterer, Armin Gerger, Birgit Grünberger, Holger Rumpold, Lukas Weiß, Thomas Winder, Richard Greil, Gerald W. Prager	2
4	Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial 2022 ·European Journal of Cancer ·Cédric Panje, Stefanie Hayoz, Wolfgang Eisterer, Viviane Hess, Peter Thuss‐Patience, (unknown), (unknown), Dorothea Wagner, Michael Girschikofsky, E.I. Eboulet, M. Stahl, Thomas Ruhstaller	2
5	Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma 2018 ·European Journal of Cancer ·Thomas Brodowicz, Olivier Mir, Jennifer Wallet, Antoîne Italiano, Jean‐Yves Blay, François Bertucci, Wolfgang Eisterer, Christine Chevreau, Sophie Piperno‐Neumann, Emmanuelle Bompas, Thomas Ryckewaert, (unknown), (unknown), Nicolas Penel, Axel Le Cesne, Marie‐Cécile Le Deley	15
6	A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients 2017 ·Supportive Care in Cancer ·(unknown), (unknown), Michael Fridrik, (unknown), Andreas Leiherer, August Zabernigg, Richard Greil, Wolfgang Eisterer, Jörg Tschmelitsch, Alois Lang, Sophie Frantal, Sonja Burgstaller, Michael Gnant, Josef Thaler	8
7	Gastrointestinal stromal tumors: Diagnosis, therapy and follow-up care in Austria 2013 ·Wiener Medizinische Wochenschrift ·Evelyne Bareck, Ahmed Ba‐Ssalamah, Thomas Brodowicz, Wolfgang Eisterer, Michael Häfner, Christoph Högenauer, Ulrike Kastner, Thomas Kühr, (unknown), Bernadette Liegl‐Atzwanger, Sebastian F. Schoppmann, Gerlig Widmann, Fritz Wrba, Johannes Zacherl, Ferdinand Ploner	10
8	Feasibility of a Multdisciplinary Lung Cancer Videoconference between a Peripheral Hospital and a Comprehensive Cancer Centre 2013 ·Oncology ·Andreas Seeber, Manfred Mitterer, Eberhard Gunsilius, Giorgia Mazzoleni, Riccardo Giovannetti, Mohsen Farsad, Wolfgang Eisterer, Guenther Gastl, Georg Pall, Andreas Wieser, Pierre Lukas, Martin L.J. Wimmer, Gilbert Spizzo	14
9	First Experience With Proteasome Inhibitor Treatment of Radioiodine Nonavid Thyroid Cancer Using Bortezomib 2012 ·Clinical Nuclear Medicine ·Daniel Putzer, Michael Gabriel, Alexander Kroiss, (unknown), Wolfgang Eisterer, Dorota Kendler, Christian Uprimny, Reto Bale, Günther Gastl, Irene Virgolini	12
10	Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe 2012 ·Supportive Care in Cancer ·(unknown), Wolfgang Eisterer, Lucie Kutikova, Sam Salek	6
11	[ ^99m Tc]Demotensin VI: Biodistribution and Initial Clinical Results in Tumor Patients of a Pilot/Phase I Study 2011 ·Cancer Biotherapy and Radiopharmaceuticals ·Michael Gabriel, Clemens Decristoforo, Ewald Wöll, Wolfgang Eisterer, Berthold A. Nock, Θεοδοσία Μάινα, Roy Moncayo, Irene Virgolini	13
12	Preoperative Oxaliplatin, Capecitabine, and External Beam Radiotherapy in Patients with Newly Diagnosed, Primary Operable, cT3NxM0, Low Rectal Cancer 2011 ·Strahlentherapie und Onkologie ·(unknown), Dietmar Öfner, Alexander DeVries, Renate Schaberl-Moser, Richard Greil, Hans Rabl, Jörg Tschmelitsch, Matthias Zitt, Karin S. Kapp, Gerd Fastner, Felix Keil, Wolfgang Eisterer, (unknown), Felix Offner, Michael Gnant, Josef Thaler	22
13	Konsensus Diagnose und Therapie von Weichteilsarkomen 2011 ·Wiener klinische Wochenschrift ·Thomas Brodowicz, Gabriele Amann, Andreas Leithner, A. Sztankay, Franz Kainberger, Wolfgang Eisterer, Bernadette Liegl‐Atzwanger, Franz Rachbauer, Timo Räth, Michael Bergmann, Philipp T. Funovics, Ferdinand Ploner, Reinhard Windhager	8
14	Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease 2005 ·Leukemia ·Wolfgang Eisterer, Xiaoyan Jiang, Oliver Christ, Hanno Glimm, (unknown), Emily M. Pang, Karen Lambie, Georgina Shaw, Tessa L. Holyoake, Andreas Petzer, Chirayu Auewarakul, M. J. Barnett, Connie J. Eaves, Allen Eaves	104
15	CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia 2002 ·Experimental Hematology ·Oliver Bechter, Wolfgang Eisterer, Margit Dlaska, Thomas Kühr, Josef Thaler	58
16	Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-β2 microglobulin–null mice 2001 ·Journal of Clinical Investigation ·Hanno Glimm, Wolfgang Eisterer, (unknown), John R. Cashman, Tessa L. Holyoake, Frank Nicolini, Leonard D. Shultz, Christof von Kalle, Connie J. Eaves	159
17	Detection and quantitation of genetically marked acute myeloid leukemia by competitive polymerase chain reaction after autologous bone marrow transplantation 1999 ·Experimental Hematology ·Thomas Kühr, Oliver Bechter, Stephan Geley, Wolfgang Eisterer, (unknown), (unknown), Hermann Dietrich, Wolfgang Hilbe, Reinhard Kofler, Josef Thaler	3
18	Decreased potency of MDR‐modulators under serum conditions determined by a functional assay 1995 ·British Journal of Haematology ·Christof Ludescher, Wolfgang Eisterer, Wolfgang Hilbe, Johann Hofmann, Josef Thaler	29
19	Treatment of relapsed and refractory acute myelogenous leukaemia with aclacinomycin A (ACA) and etoposide (VP-16) 1994 ·Leukemia Research ·Wolfgang Hilbe, Josef Thaler, Wolfgang Eisterer, Christof Ludescher, Dietger Niederwieser	5
20	Activity of P-Glycoprotein in B-Cell Chronic Lymphocytic Leukemia Determined by a Flow Cytometric Assay 1993 ·JNCI Journal of the National Cancer Institute ·Christof Ludescher, Wolfgang Hilbe, Wolfgang Eisterer, (unknown), Christian G. Huber, (unknown), Johann Hofmann, J. Thaler	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact